A study of 500 cancer patients at Tel Aviv’s Sourasky (Ichilov) Medical Center found that those who took cannabis prior to oxaliplatin chemotherapy suffered 40% less nerve damage than those who didn’t. Oxaliplatin’s neurological side effects affect 70% of cancer patients.
Reducing nerve damage from cancer treatments
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.